ScholarGate
Асистент

Сравнение на методи

Прегледайте избраните методи един до друг; редовете с разлики са откроени.

Рисково-коригирано клинично изпитване Фаза III×Мачово рандомизирано клинично изпитване×
ОбластЕпидемиологияЕпидемиология
СемействоProcess / pipelineProcess / pipeline
Година на възникване1980s–presentMid-20th century concept; methodological formalization circa 2000–2010
СъздателEvolving practice; foundational risk-adjustment principles established by Pocock (1983) and extended by numerous trialistsDeveloped formally in biostatistics literature; Greevy, Imai and colleagues advanced modern frameworks in the 2000s
ТипConfirmatory randomized trial with baseline risk stratification and covariate adjustmentExperimental clinical study design
Основополагащ източникPocock, S. J. (1983). Clinical Trials: A Practical Approach. Wiley. ISBN: 978-0471901556Imai, K., King, G., & Nall, C. (2009). The essential role of pair matching in cluster-randomized experiments, with application to the Mexican universal health insurance evaluation. Statistical Science, 24(1), 29–53. DOI ↗
Други названияrisk-stratified Phase III trial, covariate-adjusted Phase III RCT, risk-adjusted confirmatory trial, RA-Phase IIImatched RCT, matched-pair randomized trial, matched randomized controlled trial, covariate-matched RCT
Свързани66
РезюмеA risk-adjusted Phase III clinical trial is a large-scale confirmatory randomized experiment that explicitly incorporates participants' baseline prognostic risk profile into both the randomization process and the primary statistical analysis. By stratifying patients on known risk factors before allocation and adjusting for those factors in the outcome model, the design achieves greater statistical precision, reduces confounding, and produces treatment effect estimates that are more clinically meaningful across patient subgroups.A matched randomized clinical trial pairs participants (or clusters) on key baseline characteristics before randomization, then allocates one member of each pair to treatment and the other to control. This design combines the causal validity of randomization with the covariate balance of matching, increasing statistical efficiency and reducing confounding from known prognostic variables without sacrificing the internal validity of a controlled experiment.
ScholarGateНабор от данни
  1. v1
  2. 2 Източници
  3. PUBLISHED
  1. v1
  2. 2 Източници
  3. PUBLISHED

Към търсенето Изтегляне на слайдове

ScholarGateСравнение на методи: Risk-adjusted Phase III clinical trial · Matched Randomized Clinical Trial. Извлечено на 2026-06-20 от https://scholargate.app/bg/compare